cancer-2018-posters-abstracts

Page 50

allied

academies

Journal of Medical Oncology and Therapeutics | Volume: 3

July 23-25, 2018 | Moscow, Russia

World Cancer Congress

Cancer in nonagenarian: A hospital-based survival study

Manigreeva Krishnatreya, Jagannath Dev Sharma, Amal Chandra Kataki, Nizara Baishya, Mouchumee Bhattacharyya

and

Manoj Kalita

Dr Bhubaneswar Borooah Cancer Institute, India

ancers in a nonagenarian patient is rarely seen and there is

always amoral dilemma for the familymembers and patient

of whether to opt for the treatment or not. The main objective

of this study was to identify the survival differences between

treated and not treated nonagenarian cancer patients. This was

a retrospective study of Hospital-based Cancer Registry data

from2010 to 2016. The data of all nonagenarian cancer patients

were analyzed for gender distribution, leading sites of cancer,

stage distribution, types of treatment received, and survival.

The survival was calculated from the date of first diagnosis.

Kaplan-Meier analysis was done to present the survival. Of

60,087 patients, 146 (0.2%) patients were of 90 years and

above. Hypopharynx in males (20.5%) and tongue (20.5%) in

females were the top cancer sites, 60% patient data were in

stages III and IV, 37 (25.3%) patients received treatment and

86% patients were treated by radiotherapy. The overall survival

(OS) was 14.3%. OS in the treatment group was 21.3% versus

7.7% (P=0.001) in the no treatment group. The unadjusted HR

for no treatment group was 3.8 (P=0.003, CI=1.5-9.7). Selected

nonagenarian cancer patients from our population with a good

performance status should receive curative treatments in all

possible ways.